Clinical Trials on Vascular Hypotension in Switzerland

Total 1430 results

University of Zurich

Completed

Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo)

Pulmonary Hypertension

Switzerland
University of Zurich

Completed

Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy (SLT)

Ocular Hypertension | Cataract | Open Angle Glaucoma

Switzerland
University of Zurich

Unknown

IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients

Ocular Hypertension | Open Angle Glaucoma,

Switzerland
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Hypertension

Switzerland, Germany
Novartis

Completed

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

Hypertension

Switzerland, Germany
Novartis

Completed

VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients

Hypertension

Germany, Switzerland
Novartis

Completed

VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria

Hypertension

Switzerland, Germany
University of Zurich

Completed

Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension

Pulmonary Hypertension

Switzerland
Novartis

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

Hypertension

Switzerland, Germany
Novartis

Completed

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Hypertension

Germany, Switzerland
Novartis

Completed

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Hypertension

Switzerland, Germany
Novartis

Completed

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

Hypertension

Switzerland, Germany
Swiss Federal Institute of Technology

Completed

Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects?

Pre-Hypertension

Switzerland
Vincenzo Cannizzaro

Completed

Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients (COPNIC)

Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients

Switzerland
Novartis

Completed

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Hypertension

Germany, Switzerland
University of Zurich

Completed

Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil (HEXASN)

Hypertension, Pulmonary

Switzerland
University of Zurich

Completed

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil (HEXASH)

Hypertension, Pulmonary

Switzerland
University of Zurich

Completed

Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension (HEXABM)

Hypertension, Pulmonary

Switzerland
University of Zurich

Completed

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil (HEXAS)

Hypertension, Pulmonary

Switzerland
Novartis

Completed

A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Hypercholesterolemia | Essential Hypertension

Switzerland, Germany
University of Zurich

Completed

Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension (HEXA)

Hypertension, Pulmonary

Switzerland
University Hospital, Geneva
University of Lausanne Hospitals

Completed

Renal and Hormonal Effects of Pioglitazone

Hypertension | Diabetes

Switzerland
Novartis

Completed

A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

Hypertension

Switzerland, Spain, Hungary, Germany
Novartis

Completed

A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

Hypertension

Switzerland
University of Giessen
University Hospital, Zürich; Universitätsklinikum Hamburg-Eppendorf; University... and other collaborators

Unknown

The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension (PEGASUS)

Pulmonary Arterial Hypertension | Pulmonary Hypertension

Germany, Switzerland
CVRx, Inc.

Completed

Device Based Therapy in Hypertension Extension Trial (DEBuT-HET)

Hypertension

Netherlands, Switzerland, Germany
grégoire millet
Centre Hospitalier Universitaire Vaudois

Not yet recruiting

Intermittent Hypoxia-hyperoxia Conditioning as a New Therapeutic Intervention to Reduce Hypertension (HyperIHHC) (HyperIHHC)

Hypertension

Switzerland
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Hypertension

Germany, Switzerland, United Kingdom
Novartis

Completed

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

Hypertension

Switzerland, Germany
Sankyo Pharma Gmbh

Completed

Olmesartan in Essential Hypertension

Essential Hypertension

Austria, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

Essential Hypertension

Finland, Norway, Sweden, France, Germany, Italy, Turkey, Argentina, Chile, Ecuador, Spain, Switzerland
University of Zurich

Completed

Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension (CSRPH)

Pulmonary Hypertension | Breathing-Related Sleep Disorder

Switzerland
Heidelberg University
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH (ESRA)

Systemic Sclerosis | Pulmonary Vascular Disorder | Primary Pulmonary Hypertension | Other Systemic Involvement of Connective Tissue

Austria, United Kingdom, Germany, France, Switzerland, Italy
University of Zurich

Completed

Smoking: a Risk Factor for Pulmonary Arterial Hypertension? (DACH)

Pulmonary Hypertension

Switzerland, Germany, Austria
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study (SPORT)

Ocular Hypertension | Glaucoma

United Kingdom, Switzerland, Belgium, Italy, Portugal, Austria
Idorsia Pharmaceuticals Ltd.

Terminated

Tezosentan in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, France, Switzerland
Klinikum Wels-Grieskirchen
European Regional Development Fund; Austrian Society of Hypertension; I.E.M....

Completed

Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass

Suspected Arterial Hypertension

Switzerland, Austria, Germany, Greece, Italy, Spain, United Kingdom
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Active, not recruiting

COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program (COVISQAR)

Chronic Thromboembolic Pulmonary Hypertension | Myopathy | Restrictive Lung Disease | Covid19 Pneumonia

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure

Pulmonary Hypertension | Antiphospholipid Syndrome in Pregnancy | Pre-Eclampsia; Complicating Pregnancy

Switzerland
Kantonsspital Olten

Completed

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Pulmonary Artery Hypertension | Chronic Hepatitis c

Switzerland
Technische Universität Dresden
GWT-TUD GmbH

Recruiting

COMPERA / COMPERA-KIDS (COMPERA)

Pulmonary Arterial Hypertension (PAH) | Pulmonary Hypertension (PH)

Germany, Belgium, Italy, Switzerland
Novartis

Completed

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

Hypertension

Switzerland, Germany
University Hospital Inselspital, Berne

Completed

A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

Renal Failure | Renal Transplantation | Living Donors

Switzerland
University of Zurich

Unknown

Incidence of Sub-clinical Cystoid Macular Edema After Cataract Surgery (ICCME)

Glaucoma | Cataract

Switzerland
Novartis

Completed

An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

Hypertension

United States, Belgium, Denmark, Finland, Germany, Iceland, India, Switzerland
University Hospital, Geneva

Terminated

Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAG

Glaucoma and Ocular Hypertension

Switzerland
CVRx, Inc.

Completed

Device Based Therapy in Hypertension Trial (DEBuT-HT)

Hypertension

Netherlands, Switzerland, Czech Republic, Poland, Latvia, Germany
University of Zurich

Withdrawn

Effect of Catheter-based Radiofrequency Ablation Therapy in Patient With Therapy-resistant Hypertension and Sleep Apnea Syndrome

Therapy-resistant Hypertension and Sleep Apnea

Switzerland
Novartis Pharmaceuticals

Completed

Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients

Patients, Resistant Hypertension

Germany, Switzerland, United States, France, Netherlands, Denmark
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

Hypertension

Switzerland

3

Subscribe